Type 2 diabetesthe most common indication for GLP-1 therapyis independently associated with a two- to threefold increased risk of ED due to neuropathy, endothelial dysfunction, and reduced nitric oxide availability
Semaglutide ameliorates metabolic disorders in offspring via regulation of oocyte ROS of pre-pregnancy obesity mice
Therefore, monitoring thyroid parameters is advised when oral semaglutide is co-administered
Establish protocols for dose holds or reductions: Define specific criteria for when to pause titration, reduce dose, or extend time between dose increases
Upfront multimonth billing is shown before intake, while medical approval is determined later through clinician review
For patients managing chronic gut issues alongside musculoskeletal concerns, the Cleanse Hub IV is often added